24 LIfesciences trend

  According to a newly published market research report by 24LifeSciences , global Medical X-ray Film market is valued at USD 908 million in 2026 and is projected to reach USD 1,090 million by 2034 , growing at a compound annual growth rate (CAGR) of 2.7% during the forecast period. Medical X-ray Film is a specialized light-sensitive material formulated to capture diagnostic images when exposed to X-ray radiation. Despite the widespread adoption of digital radiography, these films remain essential for producing high-resolution, permanent images in various clinical settings, particularly where cost-effectiveness and reliability are prioritized. The primary product types include Thermal Film and Ink-jet Film , both of which continue to serve critical roles in global healthcare diagnostics. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7575/medical-x-ray-film-market Growing Global Healthcare Needs Sustain Market Demand The increasing pr...

  According to a newly published market research report by 24LifeSciences , global Hydroxyzine Imine market was valued at USD 797 million in 2026  and is projected to reach USD 1172 million by 2034 , growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period. Hydroxyzine Imine, a critical pharmaceutical intermediate, is the precursor in synthesizing hydroxyzine hydrochloride and hydroxyzine pamoate, which are first-generation antihistamines and central nervous system depressants. These final active pharmaceutical ingredients (APIs) are essential for medications primarily indicated to manage anxiety and provide symptomatic relief from pruritus (itching) due to allergic conditions like chronic urticaria and atopic dermatitis. Its established role in allergy and anxiety management continues to underpin its significance in both dermatology and psychiatric therapeutic areas. Download a Free Sample Report (PDF):  https://www.24lifesciences.com/down...

  According to a newly published market research report by 24LifeSciences , global Chemo Graded Nitrile Powder-free Medical Examination Gloves market is valued at USD 2.8 billion in 2026  and is projected to reach USD 4.6 billion by 2034 , growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period. Chemo Graded Nitrile Powder-free Medical Examination Gloves are specialty personal protective equipment (PPE) specifically engineered for handling hazardous drugs, particularly cytotoxic agents used in chemotherapy treatments. These gloves undergo rigorous testing per standards like ASTM D6978 to ensure superior permeation resistance, offering healthcare workers critical protection against chemical exposure. Their powder-free nature is essential for maintaining sterile environments in oncology wards, compounding pharmacies, and surgical settings, minimizing the risk of contamination and allergic reactions. Download a Free Sample Report (PDF):  ht...

  According to a newly published market research report by 24LifeSciences , global oral solid dosage contract manufacturing market is valued at USD 75.5 billion in 2026  and is projected to reach USD 117.2 billion by 2034 , growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period. Oral solid dosage (OSD) contract manufacturing involves outsourcing the production of solid-form pharmaceuticals, such as tablets, capsules, powders, and granules, to specialized third-party organizations. This business model allows pharmaceutical companies to leverage external expertise, advanced technologies, and scalable production capacity without major capital investment, which is crucial for managing the complex and regulated process of drug development and commercialization. Download a Free Sample Report (PDF):  https://www.24lifesciences.com/download-sample/8832/oral-solid-dosage-contract-manufacturing-market Rising Pharmaceutical Outsourcing and Chronic...

  According to a newly published market research report by 24LifeSciences , global next generation cancer diagnostics market was valued at USD 8,060 million in 2026  and is projected to reach USD 28,120 million by 2034 , growing at a compound annual growth rate (CAGR) of 20.0% during the forecast period. Next generation cancer diagnostics represent a paradigm shift from traditional histopathology. These advanced technologies enable highly sensitive and specific analysis of cancer biomarkers from various biological samples, with key platforms including Next Generation Sequencing (NGS) , qPCR & Multiplexing , and DNA Microarrays . These tools are fundamental for applications such as early detection, companion diagnostics, treatment selection, and minimal residual disease monitoring, enabling a more precise and personalized approach to oncology. Download a Free Sample Report (PDF):  https://www.24lifesciences.com/download-sample/8895/next-generation-cancer-diagnost...